...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: The crick didn’t rise, here’s the presentation, finally!

Excellent synopsis!..Thx.

The big question: who is selling thousands of "ZHCLF" stock at a 12-cent (US) share price??

 

Koo

Share
New Message
Please login to post a reply